Yates Robert Clifton 4

4 · Ortho Clinical Diagnostics Holdings plc · Filed Aug 4, 2021

Form 4

Period: 2021-08-02

Director

Transactions

Sale
Ordinary Shares, $0.00001 par value
2021-08-03$21.59/sh−176,149$3,803,110→ 145,242 total
Sale
Ordinary Shares, $0.00001 par value
2021-08-04$21.79/sh−140,042$3,051,515→ 5,200 total
Exercise/Conversion
Ordinary Shares, $0.00001 par value
2021-08-02$6.28/sh+23,062$144,829→ 346,942 total
Sale
Ordinary Shares, $0.00001 par value
2021-08-02$22.06/sh−25,551$563,640→ 321,391 total
Exercise/Conversion
Stock Option
2021-08-02−23,062→ 1,025,225 total
Exercise: $6.28Exp: 2024-10-22→ Ordinary Shares, $0.00001 par value (23,062 underlying)

Footnotes (6)

[F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
[F2]The Reporting Person undertakes to provide, upon request by the Securities Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions reported in this Form 4.
[F3]Represents the weighted average sales price for the price increments ranging from $21.65 to $22.51.
[F4]Represents the weighted average sales price for the price increments ranging from $21.18 to $21.94.
[F5]Represents the weighted average sales price for the price increments ranging from $21.51 to $21.92.
[F6]The stock option is fully vested and exercisable.

Documents

1 file